Products & Technology
IntroductionZstatFlu® InfoFAQViraSTAT® Info


Order ZstatFlu
Order ZstatFlu®.
Product Overview
Ordering Information
Package Insert
Performance Characteristics

Cell culture confirmation of respiratory specimens from frozen repositories and fresh isolates were collected and tested at three separate geographical locations in the United States.

ViraSTAT® and another in-vitro diagnostic kit were compared. A total of 278 specimens were examined with the FITC-labeled Anti-Parainfluenza Pool and a total of 434 specimens were examined with the FITC-labeled monoclonal antibody identification reagents.
 Para Pool  Para 1  Para 2  Para 3  
 80 specimens  52 specimens  18 specimens  101 specimens  Total Positive
 100%  98.1%1  100%  100%  Sensitivity
 100%  100%  100%  99.7%2  Specificity

1 One specimen was weakly positive with the reference comparison antibody and negative with ViraSTAT and negative with a confirming independent antibody. However, the reference antibody was considered the comparison standard.

2 One specimen was weakly negative with the reference comparison antibody but strongly positive with ViraSTAT and positive with a confirming independent antibody. However, the reference antibody was considered the comparison standard.
About UsInvestor InfoFlu101Physician ResourcesProducts & Technology HomeLinksContact UsSitemap
 
ZymeTx Web Sites:
zymetx.com
flu101.com
fluwatch.com

©2003 - ZymeTx, Inc.
ZstatFlu®, ViraZyme®,
and ViraSTAT® are trademarks of ZymeTx, Inc.